Pulmonary Arterial Hypertension Clinical Trials in Baltimore, Maryland

5 studies are recruiting for pulmonary arterial hypertension in Baltimore, Maryland right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

   Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lungs and overworks the heart. PAH can make it hard to breathe and be active. Some standard (usual) tre…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Johns Hopkins University ( Site 1036), Baltimore, Maryland

   Locations

   136 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07218029 on ClinicalTrials.gov

2. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

   The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults in hopes to find the most safe and effective dose for children. The primary objective of this study is to evaluate the PK…

   Stage

   Not phased

   Ages

   0 to 20

   Site

   University of Maryland Medical Center, Baltimore, Maryland

   Locations

   52 in total

   Run by

   Duke University

   See if you can join NCT04278404 on ClinicalTrials.gov

3. Empagliflozin to Improve Right Ventricular Function in Pulmonary Arterial Hypertension

   Randomized, triple-masked, parallel arm clinical trial of empagliflozin versus placebo in pulmonary arterial hypertension (PAH) participants on stable approved PAH-targeted medical therapy.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   The Johns Hopkins Hospital, Baltimore, Maryland

   Locations

   3 in total

   Run by

   Gustavo A Heresi, MD, MS

   See if you can join NCT06992440 on ClinicalTrials.gov

4. Pulmonary Hypertension Association Registry

   The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects information from people with PAH and CTEPH who are cared for in participating PHA-accredited Pulmonary Hypertension Care C…

   Stage

   Not phased

   Ages

   0 and older

   Site

   University of MD Medical Group, PA, Baltimore, Maryland

   Locations

   52 in total

   Run by

   Pulmonary Hypertension Association, Inc.

   See if you can join NCT04071327 on ClinicalTrials.gov

5. Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

   Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe t…

   Stage

   Not phased

   Ages

   0 to 21

   Site

   Johns Hopkins Children's Center, Baltimore, Maryland

   Locations

   14 in total

   Run by

   New York Medical College

   See if you can join NCT02249923 on ClinicalTrials.gov